Profile data is unavailable for this security.
About the company
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
- Revenue in USD (TTM)2.72bn
- Net income in USD47.00m
- Incorporated2018
- Employees12.00k
- LocationEnvista Holdings Corp200 S. Kraemer Blvd., Bldg. EBREA 92821United StatesUSA
- Phone+1 (714) 817-5418
- Fax+1 (302) 655-5049
- Websitehttps://envistaco.com/en
More ▼
Mergers & acquisitions
| Acquired company | NVST:NYQ since announced | Transaction value |
|---|---|---|
| Alpha Bio France SAS | 51.77% | -- |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10X Genomics Inc | 642.82m | -43.54m | 2.96bn | 1.18k | -- | 3.71 | -- | 4.60 | -0.3496 | -0.3496 | 5.15 | 6.24 | 0.6559 | 2.85 | 9.53 | 545,690.10 | -4.44 | -14.35 | -5.16 | -16.43 | 69.13 | 72.27 | -6.77 | -24.50 | 4.09 | -- | 0.00 | -- | 5.25 | 16.55 | 76.16 | -- | -31.16 | -- |
| Haemonetics Corp | 1.32bn | 175.44m | 2.97bn | 3.02k | 17.55 | 3.28 | 10.31 | 2.25 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.69 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| Integer Holdings Corp | 1.85bn | 102.83m | 2.97bn | 11.00k | 30.06 | 1.70 | 12.72 | 1.60 | 2.87 | 2.87 | 52.83 | 50.85 | 0.5714 | 5.37 | 4.59 | -- | 3.17 | 3.26 | 3.41 | 3.51 | 27.39 | 26.88 | 5.55 | 6.07 | 2.23 | 6.04 | 0.41 | -- | 7.98 | 11.54 | -15.05 | 5.89 | 12.09 | -- |
| ICU Medical Inc | 2.23bn | 732.00k | 3.63bn | 13.00k | 5,955.83 | 1.71 | 17.74 | 1.63 | 0.0247 | 0.0247 | 90.50 | 86.03 | 0.5406 | 2.35 | 12.28 | 171,635.50 | 0.0465 | -0.6518 | 0.0534 | -0.7376 | 36.84 | 34.16 | 0.0861 | -1.11 | 1.15 | 1.70 | 0.378 | -- | -6.33 | 11.91 | 100.62 | -61.53 | -0.6816 | -- |
| LivaNova PLC | 1.39bn | -242.47m | 3.84bn | 3.30k | -- | 3.20 | -- | 2.77 | -4.47 | -4.47 | 25.37 | 21.96 | 0.543 | 2.84 | 6.79 | 420,622.10 | -9.48 | -3.21 | -12.39 | -3.97 | 68.04 | 68.27 | -17.46 | -6.55 | 1.16 | 3.67 | 0.2389 | -- | 10.74 | 8.24 | -483.45 | -- | 18.27 | -- |
| iRhythm Holdings, Inc | 747.14m | -44.55m | 4.15bn | 2.40k | -- | 27.16 | -- | 5.56 | -1.41 | -1.41 | 23.35 | 4.73 | 0.7657 | 12.33 | 9.60 | 311,307.50 | -4.57 | -16.40 | -5.28 | -19.65 | 70.57 | 68.67 | -5.96 | -19.44 | 4.48 | -- | 0.8096 | -- | 26.24 | 23.02 | 60.67 | -- | 27.88 | -- |
| Merit Medical Systems Inc | 1.52bn | 128.49m | 4.55bn | 7.50k | 35.99 | 2.87 | 17.85 | 3.00 | 2.13 | 2.13 | 25.07 | 26.66 | 0.594 | 2.43 | 7.70 | 202,120.80 | 5.03 | 4.56 | 5.53 | 5.10 | 48.70 | 46.73 | 8.48 | 7.34 | 2.95 | 16.77 | 0.3166 | 0.00 | 11.75 | 9.48 | 6.76 | -- | 11.48 | -- |
| Stevanato Group SpA | 1.37bn | 164.31m | 4.57bn | 5.52k | 25.07 | 2.45 | 17.44 | 3.34 | 0.602 | 0.602 | 5.01 | 6.16 | 0.5058 | 2.95 | 2.65 | 247,752.80 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.82bn | 12.00k | 107.07 | 1.55 | 29.60 | 1.77 | 0.275 | 0.275 | 16.10 | 18.96 | 0.4931 | 4.62 | 6.86 | 226,625.00 | 0.8523 | -2.14 | 1.01 | -2.58 | 55.02 | 56.70 | 1.73 | -5.21 | 2.04 | 6.70 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Lantheus Holdings Inc | 1.54bn | 233.56m | 4.93bn | 1.19k | 22.69 | 4.52 | 16.23 | 3.20 | 3.36 | 3.36 | 22.33 | 16.87 | 0.7328 | 9.04 | 4.53 | 1,292,212.00 | 11.10 | 11.26 | 12.85 | 12.98 | 61.10 | 61.61 | 15.15 | 14.47 | 2.51 | -- | 0.3432 | 0.00 | 0.5019 | 35.35 | -25.25 | -- | 23.67 | -- |
| TransMedics Group Inc | 605.49m | 188.99m | 5.04bn | 898.00 | 30.88 | 10.65 | 23.31 | 8.33 | 4.76 | 4.79 | 14.94 | 13.81 | 0.6467 | 5.09 | 6.65 | 674,269.50 | 20.19 | 4.75 | 21.93 | 5.18 | 59.92 | 61.27 | 31.21 | 8.52 | 6.59 | 84.70 | 0.5199 | 0.00 | 37.13 | 88.21 | 436.58 | -- | 164.81 | -- |
| Teleflex Inc | 2.39bn | 58.53m | 5.43bn | 15.50k | 99.15 | 1.74 | 23.00 | 2.27 | 1.24 | -20.56 | 53.59 | 70.70 | 0.341 | 2.23 | 5.95 | 154,489.00 | 0.8335 | 3.12 | 0.9266 | 3.43 | 53.13 | 57.05 | 2.44 | 10.06 | 2.01 | 2.73 | 0.4581 | 28.48 | 17.25 | -4.72 | 2.34 | -29.49 | 0.9821 | 0.00 |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 5.84bn | -- | -- | 12.18 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Avantor Inc | 6.55bn | -530.20m | 6.01bn | 13.50k | -- | 1.08 | -- | 0.9171 | -0.7775 | -0.7775 | 9.62 | 8.16 | 0.5481 | 5.70 | 6.21 | 485,348.20 | -4.44 | 2.78 | -5.17 | 3.18 | 32.65 | 33.77 | -8.09 | 5.00 | 1.18 | 3.62 | 0.4149 | 0.00 | -3.41 | 0.4913 | -174.52 | -- | 15.90 | -- |
| Bruker Corp | 3.44bn | -22.50m | 6.06bn | 11.09k | -- | 2.47 | 30.44 | 1.76 | -0.1485 | -0.1485 | 22.63 | 16.15 | 0.5705 | 1.64 | 5.22 | 310,013.50 | -0.1212 | 5.07 | -0.1553 | 6.76 | 47.13 | 49.70 | -0.2124 | 7.56 | 0.8553 | 9.30 | 0.4268 | 13.19 | 2.08 | 11.57 | -119.89 | -- | 4.34 | 4.56 |
Data as of Mar 03 2026. Currency figures normalised to Envista Holdings Corp's reporting currency: US Dollar USD
53.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 14.81m | 9.01% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 14.04m | 8.54% |
| Ariel Investments LLCas of 31 Dec 2025 | 11.97m | 7.28% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 9.32m | 5.67% |
| Franklin Mutual Advisers LLCas of 31 Dec 2025 | 7.99m | 4.86% |
| Atlanta Capital Management Co. LLCas of 31 Dec 2025 | 7.38m | 4.49% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Dec 2025 | 6.06m | 3.68% |
| AllianceBernstein LPas of 31 Dec 2025 | 6.04m | 3.67% |
| Gates Capital Management, Inc.as of 31 Dec 2025 | 5.81m | 3.53% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 5.20m | 3.16% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
